Shear distribution and variability in the USP Apparatus 2 under turbulent conditions

International Journal of Pharmaceutics
Joseph KukuraFernando J Muzzio

Abstract

Computational analysis is used to examine the hydrodynamic environment within the USP Apparatus II at common operating conditions. Experimental validation of the computational model shows that the simulations of fluid motion match the dispersion of dye observed in experiments. The computations are then used to obtain data that cannot be easily measured with experiments, specifically the distribution of shear forces within the media and along the wall. Results show that the shear environment is highly non-uniform. Increasing the paddle speed from 50 to 100 rpm does not improve shear homogeneity within the apparatus. Experiments show that this uneven distribution of hydrodynamic forces is a direct cause of dissolution testing variability. This variability is large enough to cause for type II dissolution test failures, i.e., failures are a result of a vulnerability of the testing method rather than a problem with a dosage form. Future development of new dissolution tests should include evaluations of the hydrodynamic environments to eliminate this potential source of failure that is unrelated to product quality.

References

May 1, 1976·Journal of Pharmaceutical Sciences·F L Underwood, D E Cadwallader
Sep 1, 1978·Journal of Pharmaceutical Sciences·J T CarstensenV K Prasad
Feb 1, 1981·Journal of Pharmaceutical Sciences·C E Wells
Nov 9, 2001·Drug Development and Industrial Pharmacy· Paulo, J M Sousa Lobo
Aug 2, 2002·Drug Development and Industrial Pharmacy·M MoriharaS Kojim

❮ Previous
Next ❯

Citations

Jan 24, 2009·Pharmaceutical Research·Vivian GrayStephen Mayock
Jan 12, 2013·Pharmaceutical Research·Johan P BoetkerHenrik Jensen
May 18, 2013·International Journal of Pharmaceutics·Houari Ameur, Mohamed Bouzit
Sep 9, 2010·Molecular Pharmaceutics·Deanna M MudieGregory E Amidon
Mar 8, 2013·AAPS PharmSciTech·Grzegorz GarbaczSandra Klein
Dec 8, 2010·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Yelchuri Vijaya RajeshVinay Umesh Rao
Apr 2, 2008·Pharmaceutical Development and Technology·Larry E StevensAlan L Weiner
Nov 11, 2015·Drug Development and Industrial Pharmacy·Marija PetruševskaKatja Kristan
Aug 16, 2006·Drug Development and Industrial Pharmacy·M A El-MassikN A Daabis
Jan 4, 2012·Journal of Pharmaceutical Sciences·Kristyn Greco, Robin Bogner
Jan 26, 2007·Journal of Pharmaceutical Sciences·Zongming GaoBenjamin J Westenberger
Jun 28, 2011·Journal of Pharmaceutical Sciences·Zongming Gao
Oct 16, 2010·Journal of Pharmaceutical Sciences·G ShikoJ M Butler
Nov 15, 2007·Journal of Pharmaceutical Sciences·Zongming GaoWilliam H Doub
Sep 11, 2007·Journal of Pharmaceutical Sciences·Ge BaiRussell V Plank
Feb 1, 2006·Journal of Pharmaceutical Sciences·D M Kremer, B C Hancock
Sep 11, 2008·Journal of Pharmaceutical Sciences·Ge Bai, Piero M Armenante
Jun 19, 2007·Journal of Pharmaceutical Sciences·Ge BaiPaul Harmon
Mar 30, 2010·International Journal of Pharmaceutics·Wei-Guo Dai
Apr 21, 2009·International Journal of Pharmaceutics·Maziar Kakhi
Oct 19, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Saeed A Qureshi
Oct 13, 2006·International Journal of Pharmaceutics·Dave A MillerRobert O Williams
Oct 8, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Grzegorz GarbaczSandra Klein
Jun 19, 2016·International Journal of Pharmaceutics·Bing Wang, Piero M Armenante
Mar 21, 2015·Pharmaceutical Research·Hiroyuki YoshidaYukihiro Goda
Mar 9, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Diana Y Wei, Rigmor H Jensen
Dec 29, 2020·Journal of Pharmaceutical and Biomedical Analysis·Kaushalendra ChaturvediKenneth R Morris
Aug 12, 2010·Molecular Pharmaceutics·Mark McAllister
May 13, 2010·Molecular Pharmaceutics·Kristyn Greco, Robin Bogner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.